未知股票 TTOO 深 沪
已收盘
--
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 --
- 最 低 --
- 昨 收 --
- 总市值 0
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 2804.54万
- 历史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 --
- 每 手 1
- 风险率 1.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-T2 Biosystems Announces Intent To Wind Down Operations
BRIEF-T2 Biosystems Announces Intent To Wind Down Operations Feb 3 (Reuters) - T2 Biosystems Inc TTOO.PK : T2 BIOSYSTEMS, INC. ANNOUNCES INTENT TO COMPLETE WINDING DOWN OF OPERATIONS T2 BIOSYSTEMS INC - BOARD AUTHORIZED IMMEDIATE TERMINATION OF ALL EMPLOYEES T2 BIOSYSTEMS INC - COMPANY UNABLE TO COM
02-04 00:06
恩佐生化盘中异动 快速跳水5.56%报0.510美元
北京时间2025年02月12日03时33分，恩佐生化（ENZ.us）股票出现异动，股价快速下跌5.56%。截至发稿，该股报0.510美元/股，成交量26.09...
2025-02-12 03:33
BRIEF-T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement
Jan 17 (Reuters) - T2 Biosystems Inc TTOO.O: T2 BIOSYSTEMS INC - ENTERS AMENDMENT NO. 12 TO TERM LOAN AGREEMENT T2 BIOSYSTEMS INC - TWELFTH AMENDMENT WAIVES CERTAIN EVENTS OF DEFAULT UNDER THE TERM LO...
2025-01-17 22:28
梅特勒-托利多涨1.69% 股价突破1300美元大关
北京时间2025年01月17日03时45分，梅特勒-托利多（MTD.us）股票出现异动，股价急速上涨1.69%。截至发稿，该股报1301.42美元/股，成交量...
2025-01-17 03:45
Prenetics Global盘中异动 下午盘股价大跌5.43%报5.56美元
北京时间2025年01月15日02时48分，Prenetics Global（PRE.us）股票出现波动，股价急速跳水5.43%。截至发稿，该股报5.56美元...
2025-01-15 02:48
T2 Biosystems Enhances Governance and Leadership Stability
T2 Biosystems ( ($TTOO) ) has provided an update. T2 Biosystems, Inc. held its ...
2025-01-04 05:58
T2 Biosystems sells four T2Dx Instruments to European distributor
T2 Biosystems (NASDAQ:TTOO) said it will sell four T2Dx Instruments to its European distributor. The sale shows commercial expansion to help enable more utilization of the T2Bacteria Panel, the T2Can...
2024-12-18 22:20
T2 Biosystems Advances Sepsis Detection Technology Licensing
T2 Biosystems ( ($TTOO) ) has issued an update. T2 Biosystems is set to expand ...
2024-12-09 22:28
快讯 | t2 biosystems发布业绩后股价在收盘后上涨了7.7%
T2 Biosystems Rises 7.7% After the Bell Following Results
2024-11-15 05:16
T2 Biosystems Expects Q4 2024 sepsis product revenue to be $2.5M to $3.5M.
T2 Biosystems (NASDAQ:TTOO) .
2024-11-15 05:15
